HUP0203403A3 - New imidazole derivatives, pharmaceutical compositions containing them and their use - Google Patents

New imidazole derivatives, pharmaceutical compositions containing them and their use

Info

Publication number: HUP0203403A3
Authority: HU; Hungary
Prior art keywords: pharmaceutical compositions; compositions containing; imidazole derivatives; new imidazole; new
Prior art date: 1999-11-22

Application number

HU0203403A

Other languages

English (en)

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-22

Filing date

2000-11-20

Publication date

2004-01-28

2000-11-20 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2003-02-28 Publication of HUP0203403A2 publication Critical patent/HUP0203403A2/hu

2004-01-28 Publication of HUP0203403A3 publication Critical patent/HUP0203403A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Oncology (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

HU0203403A 1999-11-22 2000-11-20 New imidazole derivatives, pharmaceutical compositions containing them and their use HUP0203403A3 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US16681499P	1999-11-22	1999-11-22
US16688599P	1999-11-22	1999-11-22
US16688699P	1999-11-22	1999-11-22
US16689599P	1999-11-22	1999-11-22
PCT/US2000/031791 WO2001037835A1 (en)	1999-11-22	2000-11-20	Novel compounds

Publications (2)

Publication Number	Publication Date
HUP0203403A2 HUP0203403A2 (hu)	2003-02-28
HUP0203403A3 true HUP0203403A3 (en)	2004-01-28

Family

ID=27496721

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0203403A HUP0203403A3 (en)	1999-11-22	2000-11-20	New imidazole derivatives, pharmaceutical compositions containing them and their use

Country Status (21)

Country	Link
US (3)	US7026336B1 (hu)
EP (2)	EP1233769B1 (hu)
JP (2)	JP2003514906A (hu)
KR (1)	KR20020050294A (hu)
CN (1)	CN1543346A (hu)
AT (2)	ATE382044T1 (hu)
AU (2)	AU1529901A (hu)
BR (1)	BR0015532A (hu)
CA (1)	CA2395564A1 (hu)
CZ (1)	CZ20021746A3 (hu)
DE (2)	DE60015594T2 (hu)
ES (2)	ES2298165T3 (hu)
HK (1)	HK1050190A1 (hu)
HU (1)	HUP0203403A3 (hu)
IL (2)	IL149150A0 (hu)
MX (1)	MXPA02005106A (hu)
NO (1)	NO20022318L (hu)
NZ (1)	NZ518032A (hu)
PL (1)	PL355912A1 (hu)
TR (1)	TR200201364T2 (hu)
WO (2)	WO2001038324A2 (hu)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9828511D0 (en)	1998-12-24	1999-02-17	Zeneca Ltd	Chemical compounds
GB9919778D0 (en)	1999-08-21	1999-10-27	Zeneca Ltd	Chemical compounds
ES2298165T3 (es)	1999-11-22	2008-05-16	Smithkline Beecham Plc	Derivados de imidazol.
AU1783201A (en)	1999-11-23	2001-06-04	Smithkline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
GB0004890D0 (en)	2000-03-01	2000-04-19	Astrazeneca Uk Ltd	Chemical compounds
GB0004886D0 (en)	2000-03-01	2000-04-19	Astrazeneca Uk Ltd	Chemical compounds
GB0004888D0 (en)	2000-03-01	2000-04-19	Astrazeneca Uk Ltd	Chemical compounds
GB0004887D0 (en)	2000-03-01	2000-04-19	Astrazeneca Uk Ltd	Chemical compounds
US7235551B2 (en)	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
GB0005357D0 (en)	2000-03-06	2000-04-26	Smithkline Beecham Plc	Compounds
GB0007371D0 (en)	2000-03-28	2000-05-17	Astrazeneca Uk Ltd	Chemical compounds
GB0016877D0 (en)	2000-07-11	2000-08-30	Astrazeneca Ab	Chemical compounds
GB0021726D0 (en) *	2000-09-05	2000-10-18	Astrazeneca Ab	Chemical compounds
JP4217480B2 (ja) *	2000-11-20	2009-02-04	スミスクライン・ビーチャム・コーポレイション	新規化合物
GB0103926D0 (en)	2001-02-17	2001-04-04	Astrazeneca Ab	Chemical compounds
GB0112348D0 (en)	2001-05-19	2001-07-11	Smithkline Beecham Plc	Compounds
GB0113041D0 (en)	2001-05-30	2001-07-18	Astrazeneca Ab	Chemical compounds
WO2003022832A1 (en) *	2001-09-05	2003-03-20	Smithkline Beecham P.L.C.	Pyridylfurans and pyrroles as raf kinase inhibitors
GB0121488D0 (en) *	2001-09-05	2001-10-24	Smithkline Beecham Plc	Compounds
ES2309207T3 (es) *	2001-09-05	2008-12-16	Smithkline Beecham Plc	Derivados furanicos sustituidos con piridina como inhibidores de quinasa raf.
WO2003076434A1 (en) *	2002-03-09	2003-09-18	Astrazeneca Ab	4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
GB0205688D0 (en)	2002-03-09	2002-04-24	Astrazeneca Ab	Chemical compounds
GB0205690D0 (en)	2002-03-09	2002-04-24	Astrazeneca Ab	Chemical compounds
GB0205693D0 (en)	2002-03-09	2002-04-24	Astrazeneca Ab	Chemical compounds
AR039241A1 (es)	2002-04-04	2005-02-16	Biogen Inc	Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
BR0313078A (pt)	2002-08-06	2005-07-12	Astrazeneca Ab	Composto ou um sal deste farmaceuticamente aceitável, composição farmacêutica, e, uso do composto ou de um sal deste farmaceuticamente aceitável
US7268139B2 (en)	2002-08-29	2007-09-11	Scios, Inc.	Methods of promoting osteogenesis
EP2426122A1 (en) *	2002-10-24	2012-03-07	Merck Patent GmbH	Methylene urea derivative as RAF kinasse inhibitors
AU2003268926B2 (en) *	2002-10-24	2010-06-17	Merck Patent Gmbh	Methylene urea derivatives as raf-kinase inhibitors
GB0230089D0 (en) *	2002-12-24	2003-01-29	Astrazeneca Ab	Therapeutic agents
EP1581222A2 (en)	2003-01-02	2005-10-05	Millennium Pharmaceuticals, Inc.	COMPOSITIONS AND METHODS FOR INHIBITING TGF-&bgr;
GB0311276D0 (en)	2003-05-16	2003-06-18	Astrazeneca Ab	Chemical compounds
GB0311274D0 (en)	2003-05-16	2003-06-18	Astrazeneca Ab	Chemical compounds
AR045037A1 (es)	2003-07-10	2005-10-12	Aventis Pharma Sa	Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion.
WO2005030091A2 (en)	2003-09-25	2005-04-07	Scios Inc.	Stents and intra-luminal prostheses containing map kinase inhibitors
WO2005030151A2 (en) *	2003-10-02	2005-04-07	Irm Llc	Compounds and compositions as protein kinase inhibitors
US7250434B2 (en)	2003-12-22	2007-07-31	Janssen Pharmaceutica N.V.	CCK-1 receptor modulators
TW200528101A (en)	2004-02-03	2005-09-01	Astrazeneca Ab	Chemical compounds
CA2557359A1 (en) *	2004-02-26	2005-09-09	Hans-Peter Buchstaller	Semicarbazide derivatives as kinase inhibitors
EP1676574A3 (en)	2004-12-30	2006-07-26	Johnson & Johnson Vision Care, Inc.	Methods for promoting survival of transplanted tissues and cells
US7807832B2 (en)	2005-07-28	2010-10-05	Janssen Pharmaceutica Nv	Synthesis of 4/5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine
CA2623374A1 (en)	2005-09-30	2007-04-05	Astrazeneca Ab	Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
US7989461B2 (en)	2005-12-23	2011-08-02	Amgen Inc.	Substituted quinazolinamine compounds for the treatment of cancer
MX2008013990A (es)	2006-05-09	2009-01-29	Pfizer Prod Inc	Derivados de cicloalquilamino acidos.
US8557830B2 (en)	2007-06-07	2013-10-15	Amgen Inc.	RAF kinase modulators and methods of use
AU2008276063B2 (en)	2007-07-17	2013-11-28	Plexxikon Inc.	Compounds and methods for kinase modulation, and indications therefor
CN102015686B (zh) *	2008-03-21	2014-07-02	诺华股份有限公司	杂环化合物及其用途
US8865732B2 (en)	2008-03-21	2014-10-21	Novartis Ag	Heterocyclic compounds and uses thereof
UA103319C2 (en) *	2008-05-06	2013-10-10	Глаксосмитклайн Ллк	Thiazole- and oxazole-benzene sulfonamide compounds
EP2671891A3 (en)	2008-06-27	2014-03-05	Amgen Inc.	Ang-2 inhibition to treat multiple sclerosis
MX2012004139A (es) *	2009-10-08	2012-09-07	Glaxosmithkline Llc	Combinacion.
KR101729116B1 (ko) *	2009-10-16	2017-05-02	노바르티스 아게	조 합 물
US20120270251A1 (en) *	2009-12-22	2012-10-25	Csir	Inhibition of the activity of kinase and synthetase enzymes
CN103159735B (zh) *	2011-12-10	2015-12-09	通化济达医药有限公司	取代的咪唑激酶抑制剂
US9242969B2 (en)	2013-03-14	2016-01-26	Novartis Ag	Biaryl amide compounds as kinase inhibitors
UY36294A (es)	2014-09-12	2016-04-29	Novartis Ag	Compuestos y composiciones como inhibidores de quinasa
AU2017329090B9 (en)	2016-09-19	2019-09-05	Novartis Ag	Therapeutic combinations comprising a RAF inhibitor and a ERK inhibitor
TWI798218B (zh)	2017-05-02	2023-04-11	瑞士商諾華公司	組合療法
US10605785B2 (en) *	2017-06-07	2020-03-31	General Electric Company	Sensor system and method
MX2021013817A (es)	2019-05-13	2021-12-14	Novartis Ag	Nuevas formas cristalinas de n-(3-(2-(2-hidroxietoxi)-6-morfolinop iridin-4-il)-4-metilfenil)-2-(trifluorometil)isonicotinamida como inhibidores de raf para el tratamiento del cancer.

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3707475A (en)	1970-11-16	1972-12-26	Pfizer	Antiinflammatory imidazoles
US3940486A (en)	1971-05-10	1976-02-24	Ciba-Geigy Corporation	Imidazole derivatives in the treatment of pain
US4447413A (en) *	1980-05-08	1984-05-08	Aviation Chemical, Inc.	Drift influencing composition
US4348404A (en)	1980-07-21	1982-09-07	E. I. Du Pont De Nemours And Company	Antiinflammatory 4,5-diaryl-α-polyfluoroalkyl-1H-imidazole-2-methanamines
DD201677A5 (de)	1980-07-25	1983-08-03	Ciba Geigy	Verfahren zur herstellung von trisubstituierten imidazolderivaten
US5166214A (en)	1988-12-05	1992-11-24	Du Pont Merck Pharmaceutical Company	Use of imidazoles for the treatment of atherosclerosis
US5236917A (en)	1989-05-04	1993-08-17	Sterling Winthrop Inc.	Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5179117A (en)	1991-12-20	1993-01-12	Du Pont Merck Pharmaceutical Company	Antihypercholesterolemic 2-substituted imidazoles
US5656644A (en)	1994-07-20	1997-08-12	Smithkline Beecham Corporation	Pyridyl imidazoles
US5310748A (en)	1992-05-11	1994-05-10	The Du Pont Merck Pharmaceutical Company	Imidazoles for the treatment of atherosclerosis
DE69401486T2 (de)	1993-11-12	1997-04-30	Ishihara Sangyo Kaisha	Verfahren zur Herstellung 2-cyanoimidazol Derivate
US5620999A (en)	1994-07-28	1997-04-15	Weier; Richard M.	Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
US5514505A (en)	1995-05-15	1996-05-07	Xerox Corporation	Method for obtaining improved image contrast in migration imaging members
WO1996041645A1 (en)	1995-06-12	1996-12-27	G.D. Searle & Co.	Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
US5717100A (en)	1995-10-06	1998-02-10	Merck & Co., Inc.	Substituted imidazoles having anti-cancer and cytokine inhibitory activity
JP2000507545A (ja)	1996-03-25	2000-06-20	スミスクライン・ビーチャム・コーポレイション	Ｃｎｓ損傷についての新規な治療
WO1997036587A1 (en)	1996-04-03	1997-10-09	Merck & Co., Inc.	A method of treating cancer
EP0906307B1 (en)	1996-06-10	2005-04-27	Merck & Co., Inc.	Substituted imidazoles having cytokine inhibitory activity
ES2308068T3 (es)	1996-10-15	2008-12-01	G.D. Searle Llc	Uso de inhibidores de ciclooxigenasa-2 en el tratamiento y la prevencion de neoplasia.
PT988301E (pt)	1997-06-12	2006-10-31	Aventis Pharma Ltd	Acetais ciclicos de imidazolilo
JP2002515915A (ja)	1997-06-30	2002-05-28	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	炎症性疾患の治療で有用な２−置換イミダゾール類
GB9713726D0 (en) *	1997-06-30	1997-09-03	Ciba Geigy Ag	Organic compounds
ATE257703T1 (de)	1997-10-27	2004-01-15	Takeda Chemical Industries Ltd	1,3-thiazole als adenosine a3 rezeptor antagonisten zur behandlung von asthma, allergien und diabetes
DE69829412T2 (de)	1997-12-22	2005-07-28	Bayer Pharmaceuticals Corp., West Haven	Hemmung der raf-kinase unter verwendung von symmetrisch und unsymmetrisch substituierten harnstoffen
SK285371B6 (sk) *	1997-12-22	2006-12-07	Bayer Corporation	Aryl- a heteroaryl-substituované heterocyklické močoviny, ich použitie a farmaceutické kompozície sich obsahom
CN1302296A (zh)	1998-05-22	2001-07-04	史密丝克莱恩比彻姆公司	新的2－烷基取代咪唑化合物
WO2000001688A1 (en)	1998-07-02	2000-01-13	Sankyo Company, Limited	Five-membered heteroaryl compounds
US6207687B1 (en)	1998-07-31	2001-03-27	Merck & Co., Inc.	Substituted imidazoles having cytokine inhibitory activity
WO2000026209A1 (en)	1998-11-03	2000-05-11	Novartis Ag	Anti-inflammatory 4-phenyl-5-pyrimidinyl-imidazoles
AU2164300A (en)	1998-12-04	2000-06-26	N.V. Organon	Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin
AU4556800A (en)	1999-04-27	2000-11-10	Smithkline Beecham Plc	Novel treatment
ES2298165T3 (es)	1999-11-22	2008-05-16	Smithkline Beecham Plc	Derivados de imidazol.
GB0005357D0 (en)	2000-03-06	2000-04-26	Smithkline Beecham Plc	Compounds
US7235658B2 (en)	2000-03-06	2007-06-26	Smithkline Beecham P.L.C.	Imidazol derivatives as Raf kinase inhibitors
ATE300529T1 (de)	2000-09-21	2005-08-15	Smithkline Beecham Plc	Imidazolderivate als raf-kinase-inhibitoren
JP4217480B2 (ja)	2000-11-20	2009-02-04	スミスクライン・ビーチャム・コーポレイション	新規化合物
GB0112348D0 (en)	2001-05-19	2001-07-11	Smithkline Beecham Plc	Compounds
GB0121494D0 (en)	2001-09-05	2001-10-24	Smithkline Beecham Plc	Compounds
ES2309207T3 (es)	2001-09-05	2008-12-16	Smithkline Beecham Plc	Derivados furanicos sustituidos con piridina como inhibidores de quinasa raf.
GB0121490D0 (en)	2001-09-05	2001-10-24	Smithkline Beecham Plc	Ciompounds
WO2003022832A1 (en)	2001-09-05	2003-03-20	Smithkline Beecham P.L.C.	Pyridylfurans and pyrroles as raf kinase inhibitors
GB0121488D0 (en)	2001-09-05	2001-10-24	Smithkline Beecham Plc	Compounds
WO2003022837A1 (en)	2001-09-05	2003-03-20	Smithkline Beecham P.L.C.	Heterocycle-carboxamide derivatives as raf kinase inhibitors

2000
- 2000-11-20 ES ES00978816T patent/ES2298165T3/es not_active Expired - Lifetime
- 2000-11-20 DE DE60015594T patent/DE60015594T2/de not_active Expired - Fee Related
- 2000-11-20 ES ES00977660T patent/ES2228629T3/es not_active Expired - Lifetime
- 2000-11-20 AT AT00978816T patent/ATE382044T1/de not_active IP Right Cessation
- 2000-11-20 PL PL00355912A patent/PL355912A1/xx not_active Application Discontinuation
- 2000-11-20 MX MXPA02005106A patent/MXPA02005106A/es unknown
- 2000-11-20 AU AU15299/01A patent/AU1529901A/en not_active Abandoned
- 2000-11-20 KR KR1020027006476A patent/KR20020050294A/ko not_active Ceased
- 2000-11-20 DE DE60037597T patent/DE60037597T2/de not_active Expired - Fee Related
- 2000-11-20 BR BR0015532-2A patent/BR0015532A/pt not_active Application Discontinuation
- 2000-11-20 CA CA002395564A patent/CA2395564A1/en not_active Abandoned
- 2000-11-20 HK HK03100744.6A patent/HK1050190A1/zh unknown
- 2000-11-20 NZ NZ518032A patent/NZ518032A/en unknown
- 2000-11-20 US US10/130,019 patent/US7026336B1/en not_active Expired - Fee Related
- 2000-11-20 AT AT00977660T patent/ATE281451T1/de not_active IP Right Cessation
- 2000-11-20 EP EP00978816A patent/EP1233769B1/en not_active Expired - Lifetime
- 2000-11-20 WO PCT/GB2000/004413 patent/WO2001038324A2/en not_active Ceased
- 2000-11-20 CZ CZ20021746A patent/CZ20021746A3/cs unknown
- 2000-11-20 US US10/130,018 patent/US7189745B1/en not_active Expired - Fee Related
- 2000-11-20 HU HU0203403A patent/HUP0203403A3/hu unknown
- 2000-11-20 IL IL14915000A patent/IL149150A0/xx active IP Right Grant
- 2000-11-20 JP JP2001540087A patent/JP2003514906A/ja not_active Withdrawn
- 2000-11-20 TR TR2002/01364T patent/TR200201364T2/xx unknown
- 2000-11-20 AU AU16236/01A patent/AU1623601A/en not_active Abandoned
- 2000-11-20 JP JP2001539450A patent/JP2003514860A/ja active Pending
- 2000-11-20 WO PCT/US2000/031791 patent/WO2001037835A1/en not_active Ceased
- 2000-11-20 EP EP00977660A patent/EP1232153B1/en not_active Expired - Lifetime
- 2000-11-20 CN CNA008159491A patent/CN1543346A/zh active Pending
2002
- 2002-04-15 IL IL149150A patent/IL149150A/en not_active IP Right Cessation
- 2002-05-15 NO NO20022318A patent/NO20022318L/no not_active Application Discontinuation
2006
- 2006-09-19 US US11/533,034 patent/US20070010534A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE60015594T2 (de)	2005-10-27
HUP0203403A2 (hu)	2003-02-28
EP1233769A4 (en)	2004-12-29
ATE281451T1 (de)	2004-11-15
JP2003514906A (ja)	2003-04-22
JP2003514860A (ja)	2003-04-22
US20070010534A1 (en)	2007-01-11
EP1233769A1 (en)	2002-08-28
BR0015532A (pt)	2002-06-25
IL149150A0 (en)	2002-12-01
EP1232153B1 (en)	2004-11-03
CN1543346A (zh)	2004-11-03
US7026336B1 (en)	2006-04-11
DE60037597T2 (de)	2008-12-11
EP1233769B1 (en)	2007-12-26
NO20022318D0 (no)	2002-05-15
NO20022318L (no)	2002-05-15
US7189745B1 (en)	2007-03-13
ES2228629T3 (es)	2005-04-16
WO2001038324A2 (en)	2001-05-31
IL149150A (en)	2007-02-11
WO2001037835A1 (en)	2001-05-31
HK1050190A1 (zh)	2003-06-13
EP1232153A2 (en)	2002-08-21
TR200201364T2 (tr)	2002-10-21
DE60037597D1 (de)	2008-02-07
DE60015594D1 (de)	2004-12-09
AU1529901A (en)	2001-06-04
AU1623601A (en)	2001-06-04
CZ20021746A3 (cs)	2002-10-16
WO2001038324A3 (en)	2002-05-10
KR20020050294A (ko)	2002-06-26
ATE382044T1 (de)	2008-01-15
CA2395564A1 (en)	2001-05-31
MXPA02005106A (es)	2002-11-07
NZ518032A (en)	2004-02-27
PL355912A1 (en)	2004-05-31
ES2298165T3 (es)	2008-05-16

Publication	Publication Date	Title
HUP0203403A3 (en)	2004-01-28	New imidazole derivatives, pharmaceutical compositions containing them and their use
HUP0303069A3 (en)	2004-04-28	Imidazole derivatives, pharmaceutical compositions containing them and their use
HUP0202648A3 (en)	2003-02-28	Imidazolyl derivatives, pharmaceutical compositions containing them and their use
HUP0200714A3 (en)	2003-01-28	Pharmaceutical compounds, pharmaceutical compositions containing them and their use
HUP0400540A3 (en)	2004-09-28	2-pyrazolin-5-one derivatives, their use and pharmaceutical compositions containing them
HUP0105414A3 (en)	2003-04-28	Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
HUP0105003A3 (en)	2004-11-29	2-oxy-4h-3,1-benzoxazin-4-one derivatives, their use and pharmaceutical compositions containing them
HUP0200155A3 (en)	2005-04-28	Thioamide derivatives, pharmaceutical compositions containing them and their use
HUP0302969A3 (en)	2005-05-30	Npyy5 antagonists, pharmaceutical compositions containing them and their use
HUP0204081A3 (en)	2003-07-28	4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0400837A3 (en)	2007-11-28	2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en)	2004-07-28	1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
HUP0203548A3 (en)	2003-04-28	New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0300618A3 (en)	2003-12-29	Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0200709A3 (en)	2004-07-28	Triazole compounds with dopamine-d3-receptor affinity, pharmaceutical compositions containing them and their use
HUP0203294A3 (en)	2003-03-28	Benzodiazepine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL150346A (en)	2010-12-30	Benzazole derivatives, their preparation and pharmaceutical compositions containing them
HUP0203194A3 (en)	2004-01-28	Phenylpiperazines, pharmaceutical compositions containing them and their use
HUP0202520A3 (en)	2004-11-29	Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them
HUP0200996A3 (en)	2003-01-28	Amine derivatives, pharmaceutical compositions containing them and their use
HUP0203735A3 (en)	2005-03-29	4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0203645A3 (en)	2004-01-28	Phenylpiperazinyl derivatives, pharmaceutical compositions containing them and their use
HUP0202075A3 (en)	2003-03-28	Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL147214A0 (en)	2002-08-14	1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
HUP0203722A3 (en)	2005-03-29	Substituted phenyl-piperazine derivatives, pharmaceutical compositions containing them and their use